Clinical trial
Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery…
NCT00321698 · OHSU Knight Cancer Institute, Other · Terminated
Key facts
| NCT number | NCT00321698 |
|---|---|
| Title | Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate Cancer |
| Official title | Phase I/II Study of Preoperative Radiation and Docetaxel Activity in High Risk Localized Prostate Cancer |
| Lead sponsor | OHSU Knight Cancer Institute, Other |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Radiation |
| Interventions | Intensity-Modulated Radiation Therapy (IMRT), Docetaxel+IMRT |
| Enrollment | 25 |
| Start date | Apr 21, 2006 |
| Primary completion | Oct 1, 2009 |
| Completion | Aug 18, 2023 |
| First posted | May 4, 2006 |
| Last update posted | Aug 29, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: